| RS202247806 |
SLC25A15
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS202247807 |
SLC25A15
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome |
| RS202247811 |
CEP135
|
Health Risk |
Pathogenic |
Microcephaly 8, primary |
| RS202247812 |
KRAS
|
Health Risk |
Likely pathogenic |
Noonan syndrome 1, Noonan syndrome 1 |
| RS202247814 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS202247815 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS202247818 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS202247819 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS202247820 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS202247821 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS202247822 |
PCCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS202247823 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, PCCB-related disorder |
| RS2022547761 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2022549661 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2022550603 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2022588840 |
MCOLN1
|
Health Risk |
Pathogenic |
Lisch epithelial corneal dystrophy, Mucolipidosis type IV |
| RS2022601213 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2022607233 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2022615978 |
MCOLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2022699936 |
MCOLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2022862975 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2023146719 |
CLCNKB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2023204790 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2023231095 |
PNPLA6
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2023573141 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2023624083 |
PNPLA6
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2023694204 |
MAN2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023710111 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023718817 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023743942 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023745479 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023782686 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023783146 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023804275 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023809176 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023809731 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023847365 |
PNPLA6
|
Health Risk |
Likely pathogenic |
Ataxia-hypogonadism-choroidal dystrophy syndrome, Ataxia-hypogonadism-choroidal dystrophy syndrome |
| RS2023851530 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023852354 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023853280 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023854692 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023856348 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023921392 |
PNPLA6
|
Health Risk |
Likely pathogenic |
Ataxia-hypogonadism-choroidal dystrophy syndrome, Ataxia-hypogonadism-choroidal dystrophy syndrome |
| RS2023939487 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023968144 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023968643 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023979174 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023994157 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023994563 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2023996617 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024014272 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024015975 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024019978 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024020274 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024027294 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024028589 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024064953 |
PNPLA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2024078763 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS2024151949 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024155693 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024189461 |
MAN2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of alpha-mannosidase, Inborn genetic diseases |
| RS2024192356 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024205685 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024208039 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024210372 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024217430 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024217585 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024217737 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024226065 |
MYO5B
|
Health Risk |
Pathogenic |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS2024251717 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2024315415 |
WDR83OS
|
Health Risk |
Pathogenic |
Hypercholanemia, familial |
| RS2024330843 |
DOT1L
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2024441691 |
EPHA2
|
Health Risk |
Pathogenic |
Cataract 6 multiple types, Cataract 6 multiple types |
| RS2024442390 |
EPHA2
|
Health Risk |
Pathogenic |
— |
| RS2025018868 |
AMH
|
Health Risk |
Pathogenic |
Persistent Mullerian duct syndrome, Persistent Mullerian duct syndrome |
| RS2025577400 |
MYO5B
|
Health Risk |
Pathogenic |
— |
| RS2025722754 |
MYO5B
|
Health Risk |
Pathogenic |
DIARRHEA 2, WITH MICROVILLUS ATROPHY AND CHOLESTASIS |
| RS2025724709 |
MYO5B
|
Health Risk |
Pathogenic |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS2025943800 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, Congenital microvillous atrophy |
| RS2029867406 |
CRTAP
|
Health Risk |
Likely pathogenic |
— |
| RS2029895356 |
L2HGDH
|
Health Risk |
Pathogenic |
L-2-hydroxyglutaric aciduria, L-2-hydroxyglutaric aciduria |
| RS2030102410 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2030153941 |
COQ9
|
Health Risk |
Pathogenic |
Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome, Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome |
| RS2030200763 |
LMX1B
|
Health Risk |
Pathogenic/Likely pathogenic |
LMX1B-related disorder, Inborn genetic diseases |
| RS2030220818 |
LMX1B
|
Health Risk |
Likely pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS2030231685 |
TTLL5
|
Health Risk |
Pathogenic |
— |
| RS2030237603 |
TTLL5
|
Health Risk |
Pathogenic |
— |
| RS2030268600 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2030318562 |
SMARCB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 15 |
| RS2030323020 |
AIFM1
|
Health Risk |
Likely pathogenic |
Severe X-linked mitochondrial encephalomyopathy, Severe X-linked mitochondrial encephalomyopathy |
| RS2030326799 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
AIFM1-related disorder, Inborn genetic diseases |
| RS2030331202 |
SMARCB1
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome, Hereditary cancer-predisposing syndrome |
| RS2030333357 |
ACE
|
Health Risk |
Pathogenic |
— |
| RS2030404834 |
TUBB3
|
Health Risk |
Pathogenic |
Complex cortical dysplasia with other brain malformations 1, Complex cortical dysplasia with other brain malformations 1 |
| RS2030410834 |
TUBB3
|
Health Risk |
Conflicting classifications of pathogenicity |
TUBB3-related tubulinopathy, TUBB3-related tubulinopathy |
| RS2030416703 |
TUBB3
|
Health Risk |
Likely pathogenic |
TUBB3-related disorder, TUBB3-related disorder |
| RS2030417656 |
TUBB3
|
Health Risk |
Likely pathogenic |
Complex cortical dysplasia with other brain malformations 1, Complex cortical dysplasia with other brain malformations 1 |
| RS2030421919 |
TUBB3
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS2030427823 |
TUBB3
|
Health Risk |
Likely pathogenic |
Lissencephaly, Lissencephaly |
| RS2030438427 |
L2HGDH
|
Health Risk |
Pathogenic |
L-2-hydroxyglutaric aciduria, L-2-hydroxyglutaric aciduria |